CoCensys, Inc.: The Irvine biopharmaceutical company said...

CoCensys, Inc.: The Irvine biopharmaceutical company said it lost $5.8 million, or 36 cents a share, in the second quarter, compared to a loss of $16.1 million, or $1.70 a share, in the same period last year. The loss a year ago included $8.3 million in charges related to the acquisition of Acea Pharmaceuticals Inc. For the six-month period, the company lost $11.5 million, or 74 cents a share, compared to a loss of $20.7 million, or $2.21 per share, for the same period in 1994. The six-month loss in the 1994 periods included $14.9 million in charges related to the company’s acquisition of Acea and to cash advances to Acea before the acquisitions, CoCensys said. The company recorded revenue of $1.9 million in the second quarter and $2.1 million in the first half this year. CoCensys, a research and development company, did not have revenue in the comparable periods last year.